Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Butler

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|October 4, 2000
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivoL M Butler, D B Agus, H I Scher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylaseL M Butler, Y Webb, D B Agus, et al.
Oncogene|June 9, 2016
A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancerL A Selth, R Das, S L Townley, et al.
Oncogene|May 28, 2013
Targeting cell cycle and hormone receptor pathways in cancerC E S Comstock, M A Augello, J F Goodwin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3)D C Muller, A M Hodge, A Fanidi, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|October 4, 2000
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivoL M Butler, D B Agus, H I Scher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylaseL M Butler, Y Webb, D B Agus, et al.
Oncogene|June 9, 2016
A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancerL A Selth, R Das, S L Townley, et al.
Oncogene|May 28, 2013
Targeting cell cycle and hormone receptor pathways in cancerC E S Comstock, M A Augello, J F Goodwin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3)D C Muller, A M Hodge, A Fanidi, et al.
Pageof 5